ORDIN Nr
ORDIN
Nr. 848/709/217 din 12 septembrie 2003
privind modificarea si completarea Ordinului ministrului sanatatii si familiei,
al ministrului agriculturii, alimentatiei si padurilor si al ministrului
industriei si resurselor nr. 251/240/292/2002 pentru aprobarea Listei
cuprinzand produsele farmaceutice de uz uman si veterinar care contin substante
ce intra sub incidenta Legii nr. 143/2000 privind combaterea traficului si
consumului ilicit de droguri
ACT EMIS DE: MINISTERUL SANATATII

Nr. 848 din 12 septembrie 2003
MINISTERUL AGRICULTURII, PADURILOR, APELOR SI MEDIULUI
Nr. 709 din 24 septembrie 2003
MINISTERUL ECONOMIEI SI COMERTULUI
Nr. 217 din 20 octombrie 2003
ACT PUBLICAT IN: MONITORUL OFICIAL NR. 775 din 5 noiembrie 2003
In baza Legii nr. 143/2000 privind combaterea traficului si consumului
ilicit de droguri, cu completarile ulterioare,
in temeiul art. 2 alin. (5) din Regulamentul de aplicare a dispozitiilor
Legii nr. 143/2000 privind combaterea traficului si consumului ilicit de
droguri, aprobat prin Hotararea Guvernului nr. 1.359/2000,
in temeiul Hotararii Guvernului nr. 743/2003 privind organizarea si
functionarea Ministerului Sanatatii, al Hotararii Guvernului nr. 739/2003
privind organizarea si functionarea Ministerului Agriculturii, Padurilor,
Apelor si Mediului si al Hotararii Guvernului nr. 738/2003 privind organizarea
si functionarea Ministerului Economiei si Comertului, precum si al Referatului
de aprobare nr. M.B. 3.157/2003,
ministrul sanatatii, ministrul agriculturii, padurilor, apelor si mediului
si ministrul economiei si comertului emit urmatorul ordin:
Art. 1
Anexa la Ordinul ministrului sanatatii si familiei, al ministrului
agriculturii, alimentatiei si padurilor si al ministrului industriei si
resurselor nr. 251/240/292/2002 pentru aprobarea Listei cuprinzand produsele
farmaceutice de uz uman si veterinar care contin substante ce intra sub
incidenta Legii nr. 143/2000 privind combaterea traficului si consumului ilicit
de droguri, publicat in Monitorul Oficial al Romaniei, Partea I, nr. 572 din 2
august 2002, se inlocuieste cu anexa la prezentul ordin.
Art. 2
Ministerul Sanatatii, Ministerul Agriculturii, Padurilor, Apelor si
Mediului si Ministerul Economiei si Comertului, prin directiile de
specialitate, vor duce la indeplinire prevederile prezentului ordin.
Art. 3
Prezentul ordin va fi publicat in Monitorul Oficial al Romaniei, Partea I.
Ministrul sanatatii,
Mircea Beuran
p. Ministrul agriculturii,
padurilor, apelor si mediului,
Petre Daea,
secretar de stat
p. Ministrul economiei si comertului,
Mihai Berinde,
secretar de stat
ANEXA 1*)
*) Anexa este reprodusa in facsimil.
LISTA
cuprinzand produsele farmaceutice de uz uman si veterinar care contin substante
ce intra sub incidenta Legii nr. 143/2000 privind combaterea traficului si
consumului ilicit de droguri
A. Produse farmaceutice de uz uman autorizate pentru punerea pe piata in
Romania
a) Produse farmaceutice care contin substante din tabelul nr. II din Legea
nr. 143/2000
______________________________________________________________________________
| Denumire comuna | Denumire |Forma |Concentratia/ |Mod de
|
| internationala | comerciala |farmaceutica |forma
|prescriere|
| | | |farmaceutica |si
|
| | | | |eliberare
|
|___________________|__________________|_____________|______________|__________|
|CODEINUM |CODEINA FOSFAT |COMPR. |15 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |CODEINA FOSFAT |COMPR. |15 mg |P-RF
|
| |15 mg | | |
|
|
|__________________|_____________|______________|__________|
| |CODEINA FOSFORICA |COMPR. |15 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |CODEINA | | |
|
| |FOSFORICA-EEL |COMPR. |15 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |CODEINA FOSFORICA |COMPR. |15 mg |P-RF
|
| |15 mg | | |
|
|
|__________________|_____________|______________|__________|
| |CODEINE PHOSPHATE |COMPR. |15 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |FARMACOD |COMPR. |15 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |FOSFAT DE CODEINA |COMPR. |15 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |FOSFAT DE CODEINA |COMPR. |15 mg |P-RF
|
| |15 mg | | |
|
|___________________|__________________|_____________|______________|__________|
|COMBINATII CU |ANTALGIC |COMPR. | |P-RF
|
|CODEINA
|__________________|_____________|______________|__________|
| |ANTALGIC |COMPR. | |S
|
|
|__________________|_____________|______________|__________|
| |ARDINEX |COMPR. FILM. | |P-RF
|
| |__________________|_____________|______________|__________|
| |EFERALGAN CODEINE |COMPR. EFF. | |P-RF
|
|
|__________________|_____________|______________|__________|
| |EFERALGAN CODEINE |COMPR. EFF. | |S
|
|
|__________________|_____________|______________|__________|
| |FASCOREM |COMPR. | |S
|
| |__________________|_____________|______________|__________|
| |GELONIDA |COMPR. | |P-RF
|
|
|__________________|_____________|______________|__________|
| |GRIPECALM |COMPR. | |S
|
|
|__________________|_____________|______________|__________|
| |HIDROMORFON- |SOL. INJ. | |S/P-TS
|
| |ATROPINA | | | |
|
|__________________|_____________|______________|__________|
| |LIZADON P |CAPS. | |P-6L
|
|
|__________________|_____________|______________|__________|
| |LIZADON P |CAPS. | |S
|
|
|__________________|_____________|______________|__________|
| |NAPODOREN 30 |COMPR. |30 mg + 500 mg|P-RF
|
| |__________________|_____________|______________|__________|
| |PRODEINE |COMPR. | |P-RF
|
|___________________|__________________|_____________|______________|__________|
|DIHYDROCODEINUM |DHC CONTINUS |COMPR. RET. |90 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |DHC CONTINUS |COMPR. RET. |120 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |DHC CONTINUS |COMPR. RET. |60 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|FENTANYLUM |DUROGESIC |SIST. |2.5 mg/10 cmp |P-TS
|
| |100 micrograme/h |TRANSDERM | |
|
|
|__________________|_____________|______________|__________|
| |DUROGESIC |SIST. |2.5 mg/10 cmp |P-TS |
| |25 micrograme/h |TRANSDERM | |
|
|
|__________________|_____________|______________|__________|
| |DUROGESIC |SIST. |2.5 mg/10 cmp |P-TS
|
| |50 micrograme/h |TRANSDERM | |
|
|
|__________________|_____________|______________|__________|
| |FENTANYL |SOL. INJ. |0.05 mg/ml - |S
|
| | | |2 ml |
|
|
|__________________|_____________|______________|__________|
| |FENTANYL |SOL. INJ. |0.25 mg/5 ml |S
|
| |__________________|_____________|______________|__________|
| |FENTANYL - |SOL. INJ. |0.05 mg/ml - |S
|
| |JANSSEN | |10 ml |
|
|___________________|__________________|_____________|______________|__________|
|METHADONUM |SINTALGON |COMPR. |2.5 mg |P-TS
|
|___________________|__________________|_____________|______________|__________|
|MORPHYNUM |DOLTARD - 100 mg |COMPR. RET. |100 mg |P-TS
|
|
|__________________|_____________|______________|__________|
| |DOLTARD - 10 mg |COMPR. RET. |10 mg |P-TS
|
| |__________________|_____________|______________|__________|
| |DOLTARD - 30 mg |COMPR. RET. |30 mg |P-TS
|
|
|__________________|_____________|______________|__________|
| |DOLTARD - 60 mg |COMPR. RET. |60 mg |P-TS
|
| |__________________|_____________|______________|__________|
| |MORFINA |SOL. INJ. |2 mg/ml - 1 ml|P-TS
|
|
|__________________|_____________|______________|__________|
| |MST CONTINUS(R) |COMPR. FILM. |100 mg |P-TS
|
| |100 mg |ELIB. MOD. | |
|
|
|__________________|_____________|______________|__________|
| |MST CONTINUS(R) |COMPR. FILM. |200 mg |P-TS
|
| |200 mg |ELIB. MOD. | |
|
|
|__________________|_____________|______________|__________|
| |MST CONTINUS(R) |COMPR. FILM. |30 mg |P-TS
|
| |30 mg |ELIB. MOD. | |
|
|
|__________________|_____________|______________|__________|
| |MST CONTINUS(R) |COMPR. FILM. |60 mg |P-TS
|
| |60 mg |ELIB. MOD. | |
|
|
|__________________|_____________|______________|__________|
| |SEVREDOL |COMPR. FILM. |10 mg |P-TS
|
|
|__________________|_____________|______________|__________|
| |SEVREDOL |COMPR. FILM. |20 mg |P-TS
|
|
|__________________|_____________|______________|__________|
| |SKENAN LP |CAPS. RET. |10 mg |P-TS
|
|
|__________________|_____________|______________|__________|
| |SKENAN LP |CAPS. RET. |30 mg |P-TS
|
| |__________________|_____________|______________|__________|
| |SKENAN LP |CAPS. RET. |60 mg |P-TS
|
|
|__________________|_____________|______________|__________|
| |SKENAN LP |CAPS. RET. |100 mg |P-TS
|
|
|__________________|_____________|______________|__________|
| |VENDAL RETARD |COMPR. FILM. |30 mg |
|
| | |RET. | |
|
|
|__________________|_____________|______________|__________|
| |VENDAL RETARD |COMPR. FILM. |60 mg |
|
| | |RET. | |
|
|
|__________________|_____________|______________|__________|
| |VENDAL RETARD |COMPR. FILM. |100 mg |
|
| | |RET. | |
|
|
|__________________|_____________|______________|__________|
| |VENDAL RETARD |COMPR. FILM. |10 mg |P-TS
|
| | |RET. | | |
|
|__________________|_____________|______________|__________|
| |VENDAL RETARD |COMPR. FILM. |30 mg |P-TS
|
| | |RET. | |
|
| |__________________|_____________|______________|__________|
| |VENDAL RETARD |COMPR. FILM. |60 mg |P-TS
|
| | |RET. | |
|
| |__________________|_____________|______________|__________|
| |VENDAL RETARD |COMPR. FILM. |100 mg |P-TS
|
| | |RET. | |
|
|___________________|__________________|_____________|______________|__________|
|OXYCODONUM |OXYCONTIN(R) |COMPR. FILM. |20 mg |P-TS
|
| |20 mg |ELIB. MODIF. | |
|
| |__________________|_____________|______________|__________|
| |OXYCONTIN(R) |COMPR. FILM. |40 mg |P-TS
|
| |40 mg |ELIB. MODIF. | |
|
| |__________________|_____________|______________|__________|
| |OXYCONTIN(R) |COMPR. FILM. |80 mg |P-TS
|
| |80 mg |ELIB. MODIF. | |
|
|___________________|__________________|_____________|______________|__________|
|PETHIDINUM |MIALGIN |SOL. INJ. |5 mg/ml - 2 ml|P-TS
|
|___________________|__________________|_____________|______________|__________|
b) Produse farmaceutice care contin substante din tabelul nr. III din Legea
nr. 143/2000
______________________________________________________________________________
| Denumire comuna | Denumire |Forma |Concentratia/ |Mod de
|
| internationala | comerciala |farmaceutica |forma
|prescriere|
| | | |farmaceutica |si
|
| | | | |eliberare
|
|___________________|__________________|_____________|______________|__________|
|ALPRAZOLAMUM |ALPRAZOLAM |COMPR. |0.25 mg |P-RF
|
| |0.25 mg | | |
|
|
|__________________|_____________|______________|__________|
| |ALPRAZOLAM |COMPR. |0.25 mg |S
|
| |0.25 mg | | |
|
|
|__________________|_____________|______________|__________|
| |ALPRAZOLAM |COMPR. |0.5 mg |S
|
| |0.5 mg | | |
|
|
|__________________|_____________|______________|__________|
| |ALPRAZOLAM |COMPR. |0.5 mg |P-RF
|
| |0.5 mg | | |
|
|
|__________________|_____________|______________|__________|
| |ALPRAZOLAM |COMPR. |1 mg |P-RF
|
| |1 mg | | |
|
|
|__________________|_____________|______________|__________|
| |ALPRAZOLAM |COMPR. |1 mg |S
|
| |1 mg | | |
|
|
|__________________|_____________|______________|__________|
| |FRONTIN |COMPR. |1 mg |S
|
| |__________________|_____________|______________|__________|
| |FRONTIN |COMPR. |1 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |FRONTIN |COMPR. |0.5 mg |S
|
|
|__________________|_____________|______________|__________|
| |FRONTIN |COMPR. |0.5 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |FRONTIN |COMPR. |0.25 mg |S
|
|
|__________________|_____________|______________|__________|
| |FRONTIN |COMPR. |0.25 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |HELEX |COMPR. |0.25 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |HELEX |COMPR. |0.5 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |HELEX |COMPR. |1 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |NEUROL(R) 0,25 |COMPR. |0.25 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |NEUROL(R) 1,0 |COMPR. |1 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |XANAX |COMPR. |0.25 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |XANAX |COMPR. |0.5 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |XANAX |COMPR. |1 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |XANAX |COMPR. |2 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |XANAX(R) XR |COMPR. ELIB. |0.5 mg |P-RF
|
| | |PREL. | |
|
| |__________________|_____________|______________|__________|
| |ZOLAREM 0.5 |COMPR. |0.5 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|AMFEPRAMONUM |REGENON |CAPS. |25 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|AMOBARBITALUM |AMITAL 200 |COMPR. |200 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |AMOBARBITAL |COMPR. |100 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|BROMAZEPAMUM |BROMAZEPAM |COMPR. |1.5 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |BROMAZEPAM |COMPR. |1.5 mg |S
|
|
|__________________|_____________|______________|__________|
| |BROMAZEPAM |COMPR. |3 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |BROMAZEPAM |COMPR. |3 mg |S
|
| |__________________|_____________|______________|__________|
| |BROMAZEPAM 1,5 mg |COMPR. |1.5 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |BROMAZEPAM 3 mg |COMPR. |3 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |CALMEPAM(R) |COMPR. |1.5 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |CALMEPAM(R) |COMPR. |3 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |LEXOTANIL |COMPR. |3 mg |
|
| |__________________|_____________|______________|__________|
| |LEXOTANIL(R) |COMPR. |3 mg |P-RF
|
| |(LEXOTAN) | | |
|
|___________________|__________________|_____________|______________|__________|
|CHLORDIAZEPOXIDUM |NAPOTON |DRAJ. |10 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|CLONAZEPAMUM |RIVOTRIL |COMPR. |0.5 mg |P-6L
|
|
|__________________|_____________|______________|__________|
| |RIVOTRIL(R) |COMPR. |2 mg |P-6L
|
|___________________|__________________|_____________|______________|__________|
|CYCLOBARBITALUM |CICLOBARBITAL |COMPR. |200 mg |P-RF
|
| |sare de c. | | |
|
|___________________|__________________|_____________|______________|__________|
|DIAZEPAMUM |CALMPOSE |SOL. INJ. |10 mg/2 ml |S
|
|
|__________________|_____________|______________|__________|
| |DIAZEPAM |SOL. INJ. |5 mg/ml - 2 ml|S |
|
|__________________|_____________|______________|__________|
| |DIAZEPAM |SOL. INJ. |5 mg/ml - 2 ml|P-RF
|
|
|__________________|_____________|______________|__________|
| |DIAZEPAM |SOL. INJ. |5 mg/ml - 2 ml|P-RF
|
|
|__________________|_____________|______________|__________|
| |DIAZEPAM |SOL. INJ. |5 mg/ml - 2 ml|S
|
| |__________________|_____________|______________|__________|
| |DIAZEPAM |COMPR. |5 mg |S
|
|
|__________________|_____________|______________|__________|
| |DIAZEPAM |COMPR. |5 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |DIAZEPAM |COMPR. |10 mg |S
|
| |__________________|_____________|______________|__________|
| |DIAZEPAM |COMPR. |10 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |DIAZEPAM 10 mg |COMPR. |10 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |DIAZEPAM 10 mg |COMPR. |10 mg |S
|
| |__________________|_____________|______________|__________|
| |DIAZEPAM 2 mg |COMPR. |2 mg |S
|
|
|__________________|_____________|______________|__________|
| |DIAZEPAM 2 mg |COMPR. |2 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |DIAZEPAM |SOL. RECTALA |5 mg/2.5 ml |P-RF
|
| |DESITIN(R) SOL. | | |
|
| |__________________|_____________|______________|__________|
| |DIAZEPAM |SOL. RECTALA |10 mg/2.5 ml |P-RF
|
| |DESITIN(R) SOL. | | |
|
|___________________|__________________|_____________|______________|__________|
|FLUNITRAZEPAMUM |FLUNITRAZEPAM |COMPR. |1 mg |S
|
|
|__________________|_____________|______________|__________|
| |FLUNITRAZEPAM |COMPR. |1 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |FLUNITRAZEPAM |COMPR. |2 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |FLUNITRAZEPAM |COMPR. |2 mg |S
|
|
|__________________|_____________|______________|__________|
| |FLUNITRAZEPAM |COMPR. |1 mg |S
|
|
|__________________|_____________|______________|__________|
| |FLUNITRAZEPAM |COMPR. |1 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |FLUNITRAZEPAM |COMPR. |2 mg |S
|
|
|__________________|_____________|______________|__________|
| |FLUNITRAZEPAM |COMPR. |2 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |NILIUM |COMPR. |2 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |ROHYPNOL(R) |COMPR. FILM. |1 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |ROHYPNOL(R) 1 mg |COMPR. FILM. |1 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|GLUTETHIMIDUM |GLUTETIMID |COMPR. |250 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|LORAZEPAMUM |LORIVAN |COMPR. |1 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|MEDAZEPAMUM |ANSILAN |CAPS. |10 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |EUROZEPAM |CAPS. |10 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |MEDAZEPAM 10 mg |COMPR. |10 mg |P-RF |
|
|__________________|_____________|______________|__________|
| |RUDOTEL |COMPR. |10 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |RUSEDAL |COMPR. |10 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|MEPROBAMATUM |MEPROBAMAT |COMPR. |400 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
|MIDAZOLAMUM |DORMICUM |SOL. INJ. |1 mg/ml - 5 ml|S
|
|
|__________________|_____________|______________|__________|
| |DORMICUM |SOL. INJ. |5 mg/ml - 1 ml|S
|
|
|__________________|_____________|______________|__________|
| |DORMICUM(R) |COMPR. FILM. |7.5 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |DORMICUM(R) |COMPR. FILM. |7.5 mg |P-RF
|
| |7,5 mg | | |
|
| |__________________|_____________|______________|__________|
| |FULSED INJECTION |SOL. INJ. |1 mg/ml - 5 ml|S
|
|
|__________________|_____________|______________|__________|
| |FULSED INJECTION |SOL. INJ. |1 mg/ml - |S |
| | | |10 ml |
|
|
|__________________|_____________|______________|__________|
| |FULSED INJECTION |SOL. INJ. |5 mg/ml - 1 ml|S
|
|___________________|__________________|_____________|______________|__________|
|NITRAZEPAMUM |NITRAZEPAM |COMPR. |2.5 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |NITRAZEPAM 2,5 mg |COMPR. |2.5 mg |S
|
|
|__________________|_____________|______________|__________|
| |NITRAZEPAM 2,5 mg |COMPR. |2.5 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |NITRAZEPAM 5 mg |COMPR. |5 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |NITRAZEPAM 5 mg |COMPR. |5 mg |S
|
|___________________|__________________|_____________|______________|__________|
|OXAZEPAMUM |OXAZEPAM |COMPR. |10 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |OXAZEPAM |COMPR. |10 mg |S
|
|___________________|__________________|_____________|______________|__________|
|PENTAZOCINUM |FORTRAL |SOL. INJ. |30 mg/ml |S/P-RF
|
|
|__________________|_____________|______________|__________|
| |FORTRAL |COMPR. |50 mg |S/P-RF
|
|
|__________________|_____________|______________|__________|
| |FORTWIN(R) |SOL. INJ. |30 mg/ml - |S/P-RF
|
| | | |1 ml |
|
|
|__________________|_____________|______________|__________|
| |SALDOREN(R) |SOL. INJ. |30 mg/ml - |P-RF
|
|___________________|__________________|_____________|______________|__________|
|PHENOBARBITALUM |FENOBARBITAL |COMPR. |15 mg |P-RF
|
| |__________________|_____________|______________|__________|
| |FENOBARBITAL |COMPR. |100 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |FENOBARBITAL |SOL. INJ. |4% - 1 ml |P-RF
|
|
|__________________|_____________|______________|__________|
| |FENOBARBITAL |SOL. INJ. |4% - 1 ml |S
|
| |__________________|_____________|______________|__________|
| |FENOBARBITAL |SOL. INJ. |10% - 2 ml |S
|
|
|__________________|_____________|______________|__________|
| |FENOBARBITAL |SOL. INJ. |10% - 2 ml |P-RF
|
|___________________|__________________|_____________|______________|__________|
|TETRAZEPAMUM |MYOLASTAN(R) 50 mg|COMPR. FILM. |50 mg |P-RF
|
|
|__________________|_____________|______________|__________|
| |RELAXAM |COMPR. FILM. |50 mg |P-RF
|
|___________________|__________________|_____________|______________|__________|
c) Produse farmaceutice care contin substante din tabelul nr. IV din Legea
nr. 143/2000
______________________________________________________________________________
| Denumire comuna | Denumire |Forma |Concentratia/ |Mod de
|
| internationala | comerciala |farmaceutica |forma
|prescriere|
| | | |farmaceutica |si
|
| | | | |eliberare
|
|___________________|__________________|_____________|______________|__________|
|EPHEDRINI |EFEDRINA |SOL. INJ. |10 mg/ml - |S
|
|HYDROCHLORIDUM | | |1 ml |
|
|___________________|__________________|_____________|______________|__________|
|EPHEDRINI |EFEDRINA |SOL. INJ. |50 mg/ml - |S
|
|HYDROCHLORIDUM | | |1 ml |
|
|___________________|__________________|_____________|______________|__________|
|EPHEDRINI |EFEDRINA |COMPR. |50 mg |P-RF
|
|HYDROCHLORIDUM | | | |
|
|___________________|__________________|_____________|______________|__________|
|EPHEDRINI |EFEDRINA 1% |SOL. INJ. |10 mg/ml - |S
|
|HYDROCHLORIDUM | | |1 ml |
|
|___________________|__________________|_____________|______________|__________|
|EPHEDRINI |EFEDRINA 5% |SOL. INJ. |50 mg/ml - |S
|
|HYDROCHLORIDUM | | |1 ml |
|
|___________________|__________________|_____________|______________|__________|
|ERGOMETRINUM |ERGOMET |SOL. INJ. |0.2 mg/ml - |P-RF
|
| | | |1 ml |
|
|___________________|__________________|_____________|______________|__________|
|ERGOMETRINUM |ERGOMET |SOL. INJ. |0.2 mg/ml - |S
|
| | | |1 ml |
|
|___________________|__________________|_____________|______________|__________|
|ERGOTAMINUM |DISTONOCALM |COMPR. FILM. | |P-6L
|
|COMBINATIE | | | |
|
|___________________|__________________|_____________|______________|__________|
|ERGOTAMINUM |COFEDOL |COMPR. FILM. | |P-6L
|
|COMBINATIE | | | |
|
|___________________|__________________|_____________|______________|__________|
|METHYLERGOMETRINUM |METERGINE |COMPR. |0.125 mg |S
|
|___________________|__________________|_____________|______________|__________|
|METHYLERGOMETRINUM |METILERGOMETRINA |DRAJ. |0.125 mg |S
|
| |MALEAT | | |
|
|___________________|__________________|_____________|______________|__________|
|PSEUDOEPHEDRINUM |CLARINASE |COMP. ELIB. | |P-6L
|
|COMBINATIE | |MODIF. | |
|
|___________________|__________________|_____________|______________|__________|
NOTA:
Ultima rubrica "Modul de prescriere si eliberare" cuprinde modul
de eliberare stabilit conform art. 3 si 4 din Ordonanta de urgenta a Guvernului
nr. 152/1999 privind produsele medicamentoase de uz uman, aprobata cu
modificari prin Legea nr. 336/2002, cu modificarile si completarile ulterioare,
mod de eliberare codificat potrivit Ordinului ministrului sanatatii si familiei
nr. 35 din 21 ianuarie 2003, astfel:
- S = produse medicamentoase care se utilizeaza numai in spatii cu
destinatie speciala (spitale, dispensare etc.);
- P-6L = produse medicamentoase care se elibereaza in farmacii pe baza de
prescriptie medicala valabila 6 luni;
- P-RF = produse medicamentoase care se elibereaza in farmacii pe baza de
prescriptie medicala care se retine la farmacie;
- P-TS = produse medicamentoase care se elibereaza in farmacii pe baza de
reteta cu timbru sec.
B. Produse farmaceutice de uz uman utilizate in scop veterinar si de uz
veterinar care contin substante ce intra sub incidenta Legii nr. 143/2000
(tabelele nr. II si III)
______________________________________________________________________________
| Denumire comuna | Denumire |Forma |Concentratia/ |Mod de
|
| internationala | comerciala |farmaceutica |forma |prescriere|
| | | |farmaceutica |si
|
| | | | |eliberare
|
|___________________|__________________|_____________|______________|__________|
|PETHIDINUM* |MIALGIN (um)* |SOL. INJ. |5% - fl. x |P-TS |
| | | |250 ml |
|
|___________________|__________________|_____________|______________|__________|
|PHENTOBARBITAL |EUTHANYL (vet)* |SOL. INJ. |10 ml |P-RF |
|NATRIUM | | | |
|
|___________________|__________________|_____________|______________|__________|
*) Substanta si produsul farmaceutic sunt supuse regimului stabilit prin
prevederile Legii nr. 73/1969 privind regimul produselor si substantelor
stupefiante.
*) um = medicament de uz uman utilizat si in scop veterinar.
vet = medicament de uz veterinar.
NOTA:
P TS = prescriptie medicala cu timbru sec;
P RF = prescriptie medicala care se retine in farmacie.